scispace - formally typeset
Open AccessJournal ArticleDOI

Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management

Reads0
Chats0
TLDR
The most important aspects of patient management are a high index of suspicion and a careful history of drug exposure in an individual who presents with acute, often severe thrombocytopenia of unknown etiology.
About
This article is published in Journal of Thrombosis and Haemostasis.The article was published on 2009-06-01 and is currently open access. It has received 280 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Evaluation of spontaneous gingival bleeding and related drug withdrawal frequency in atrial fibrillation patients using oral anticoagulants: a case-controlled study

TL;DR: OAK tedavisi altindaki AF hastalarinda, onceden var olan periodontal hastalik nedeniyle onemli oranda SDK ve buna bagli hastanin OAK ilac kullanimini biraktigi tespit edildi risk indikatorudur.
Journal ArticleDOI

Immune Thrombocytopenia: A Rare Adverse Event of Vancomycin Therapy

Opeyemi Tobalesi
- 01 May 2023 - 
TL;DR: In this paper , a case of a 56-year-old male with a diabetic foot with an infected exudating purulent ulcer was found to have vancomycin-induced immune thrombocytopenia.
Journal ArticleDOI

Refractory immune thrombocytopenia (ITP) with suspected Evans syndrome requiring quadruple therapy

TL;DR: This case of recurrent severe form of ITP is reported, which is not only unique due to the aggressive treatment required, but also because patient also had investigation results suggestive of autoimmune hemolytic anemia raising suspicion of Evans Syndrome.
Journal ArticleDOI

Management of Select Thrombocytopenias.

TL;DR: The pathophysiology, patient presentation, diagnostic testing, and specific management strategies and challenges of these thrombocytopenias are reviewed.
References
More filters
Journal ArticleDOI

Heparin-induced thrombocytopenia.

TL;DR: The aim of this article is to review the most recent advances in the field and to give critical guidelines for the clinical diagnosis and treatment of HIT II, the most frequent and dangerous side-effect of heparin therapy.
Journal ArticleDOI

Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity : an explanation for the thrombotic complications of heparin-induced thrombocytopenia

TL;DR: Observations indicate that the generation of procoagulant platelet-derived microparticles in vivo is a plausible explanation for the thrombotic complications observed in some patients with heparin-inducedThrombocytopenia.
Journal ArticleDOI

Drug-Induced Immune Thrombocytopenia

TL;DR: The current understanding of pathogenesis is summarized and a guide for diagnosis and management of thrombocytopenia is provided.
Journal ArticleDOI

Drug-Induced Thrombocytopenia: A Systematic Review of Published Case Reports

TL;DR: This systematic review analyzed all published reports of drug-induced thrombocytopenia by using explicit, a priori criteria for establishing levels of evidence of a causal relation to help clinicians better understand the likelihood that a drug will cause throm bocy topenia.
Journal ArticleDOI

Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function.

TL;DR: Fab fragments of certain antibodies against LIBS on integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) block platelet aggregation, and changes in the conformation of this integrin modulate both the specificity and affinity of ligand recognition.
Related Papers (5)